[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346730-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346730-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","tumor-treating-fields-ttfields-and-their-concomitant-application-with-folfox-are-effective-for-the-treatment-of-gastric-cancer-cells-original-research","Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells - Original Research","","Tumor Treating Fields (TTFields) are electric fields that inhibit mitosis and disrupt DNA damage repair in cancer cells. Gastric cancer remains associated with poor long-term survival and chemotherapy resistance despite therapeutic advances. This study evaluates the in vitro efficacy and mechanism of TTFields for gastric cancer using AGS and KATOIII cell lines, and tests the potential of TTFields combined with FOLFOX, a regimen based on oxaliplatin and 5-fluorouracil (5-FU).",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tumor-treating-fields-ttfields-and-their-concomitant-application-with-folfox-are-effective-for-the-treatment-of-gastric-cancer-cells-original-research/346730/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tumor-treating-fields-ttfields-and-their-concomitant-application-with-folfox-are-effective-for-the-treatment-of-gastric-cancer-cells-original-research/346730.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are TTFields and what effects do they target in cancer cells?","Question",{"text":63,"@type":64},"TTFields are electric fields that exert antimitotic effects and impair DNA damage repair in cancerous cells. In gastric cancer cells, this includes disruption of DNA repair processes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the study assess the efficacy of TTFields in gastric cancer cells?",{"text":68,"@type":64},"Human gastric cancer cell lines (AGS and KATOIII) were treated with TTFields using the inovitro system. Cell count, colony formation, and apoptosis were evaluated, and RNA sequencing plus protein and staining assays were used for mechanism.",{"name":70,"@type":61,"acceptedAnswer":71},"Is TTFields combined with FOLFOX more effective than either treatment alone?",{"text":72,"@type":64},"Yes. The combination of TTFields with oxaliplatin, 5-FU, or FOLFOX was more effective than each treatment alone, consistent with increased accumulation of DNA damage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346730,1790377818,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":113,"preview_page_count":33,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","TYPE Original Research PUBLISHED 09 March 2026  \nDOI 10.3389/fonc.2026.1575083  \nOPEN ACCESS  \nEDITED BY  \nDavid A. Gewirtz,  \nVirginia Commonwealth University, United States  \nREVIEWED BY  \nMarc Philipp Schauer,  \nUniversity Hospital Würzburg, Germany Michael Dean Story,  \nMayo Clinic Florida, United States  \n*CORRESPONDENCE  \nMoshe Giladi  \n [mosheg@novocure.com](mosheg@novocure.com)  \n†These authors have contributed equally to this work and share ﬁrst authorship  \n‡Deceased  \nRECEIVED 12 February 2025  \nREVISED 12 February 2026  \nACCEPTED 16 February 2026  \nPUBLISHED 09 March 2026  \nCITATION  \nFishman H, Ene HM, Zeevi E, FlintBrodsly N, Wainer-Katsir K, FrechtelGerzi R, Martinez-Conde A,  \nGreenstein S, Dor-On E, Munster M, Porat Y, Voloshin T, Davidi S, LavyShahaf G, Haber A, Giladi M, Weinberg U and Palti Y (2026) Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells. Front. Oncol. 16:1575083 .  \ndoi: 10.3389/fonc.2026.1575083  \nCOPYRIGHT  \n© 2026 Fishman, Ene, Zeevi, Flint-Brodsly, Wainer-Katsir, Frechtel-Gerzi, MartinezConde, Greenstein, Dor-On, Munster, Porat, Voloshin, Davidi, Lavy-Shahaf, Haber, Giladi, Weinberg and Palti. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells  \nHila Fishman †, Hila M. Ene †, Einav Zeevi, Naama Flint-Brodsly, Kerem Wainer-Katsir, Roni Frechtel-Gerzi,  \nAntonia Martinez-Conde, Shany Greenstein, Eyal Dor-On, Mijal Munster, Yaara Porat, Tali Voloshin, Shiri Davidi, Gitit Lavy-Shahaf, Adi Haber, Moshe Giladi*, Uri Weinberg and Yoram Palti ‡  \nNovocure Ltd., Haifa, Israel  \nBackground: Tumor Treating Fields (TTFields) are electric ﬁelds that exert antimitotic effects and impair DNA damage repair in cancerous cells. Gastric cancer, one of the most common types of cancers worldwide, demonstrates poor long-term survival despite advances in therapeutic options. The goal of the current study was to examine in vitro the efﬁcacy and mechanism of action of TTFields for treating gastric cancer, and the potential application of TTFields concomitant with FOLFOX, a standard gastric cancer treatment consisting of the therapeutic agents oxaliplatin and 5-ﬂuorouracil [5-FU] .  \nMethods: Human gastric cancer cell lines, AGS and KATOIII, were treated with TTFields using the inovitro system. To test the efﬁcacy of TTFields (alone or together with oxaliplatin, 5-FU, or FOLFOX), cell count, colony formation, and apoptosis were examined. For mechanistic insight, control and TTFields-treated cells were examined by RNA sequencing. Immunoﬂuorescent staining for phospho-histone H2AX (gH2AX), a-tubulin, phospho-histone 3 (pH3), and double stranded DNA was employed for detection of DNA damage, mitotic spindle defects, chromosome mislocalization, and micronuclei clusters, respectively. Expression of DNA damage repair proteins was measured using Western Blot.  \nResults: Maximal cell count reduction following application of TTFields at various frequencies was identiﬁed at 150 kHz. Treatment also led to reduced colony formation, elevated apoptosis, and substantial changes in transcriptomic expression. TTFields-treated cells demonstrated increased DNA damage, elevated expression of DNA damage-related cyclin-dependent kinase (CDK) inhibitors, and reduced expression of proteins from the Fanconi Anemia-BRCA pathway for DNA repair. Treated cells further presented with abnormal mitotic ﬁgures, chromosome mislocalization,","cbCaikHC8qfcX7X7","https://ap.wps.com/l/cbCaikHC8qfcX7X7","pdf",17004790,12,"English","# Introduction\n## Rationale and current treatment context\n# Methods\n## Cell lines and TTFields application\n## Efficacy assays and mechanistic analyses\n# Results\n## Frequency-dependent effects and cellular outcomes\n## DNA damage, repair pathway changes, and antimitotic findings\n## Combination with FOLFOX","[{\"question\":\"What are TTFields and what effects do they target in cancer cells?\",\"answer\":\"TTFields are electric fields that exert antimitotic effects and impair DNA damage repair in cancerous cells. In gastric cancer cells, this includes disruption of DNA repair processes.\"},{\"question\":\"How did the study assess the efficacy of TTFields in gastric cancer cells?\",\"answer\":\"Human gastric cancer cell lines (AGS and KATOIII) were treated with TTFields using the inovitro system. Cell count, colony formation, and apoptosis were evaluated, and RNA sequencing plus protein and staining assays were used for mechanism.\"},{\"question\":\"Is TTFields combined with FOLFOX more effective than either treatment alone?\",\"answer\":\"Yes. The combination of TTFields with oxaliplatin, 5-FU, or FOLFOX was more effective than each treatment alone, consistent with increased accumulation of DNA damage.\"}]","Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells - Original Research | PDF",1790062564,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c60f05ca0fd40e3720830717c4f789ba.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09e63fa15a56df50083c5b13e72bebd8.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c406215a00ef507ce0960c14e01849bf.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/621aad521133164b4f7bb585db046d5f.webp",980,1385]